US Stock MarketDetailed Quotes

CRXT CLARUS THERAPEUTICS HLDGS INC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 24 09:30 ET
0Market Cap0.00P/E (TTM)

CLARUS THERAPEUTICS HLDGS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.51%-17.5M
-145.21%-17.27M
-5.31%-43.79M
-57.70%-9.33M
-12.52M
-14.89M
-7.04M
-41.58M
-5.92M
Net income from continuing operations
40.97%-10.69M
3.62%-14.87M
-1,034.80%-40.62M
-1,647.48%-4.3M
---2.77M
---18.12M
---15.43M
--4.35M
--278K
Operating gains losses
---728K
---642K
80.86%-12.8M
62.43%-4.9M
----
----
----
---66.89M
---13.04M
Depreciation and amortization
0.00%7K
40.00%7K
38.89%25K
75.00%7K
--6K
--7K
--5K
--18K
--4K
Other non cash items
-58.58%2.02M
-181.57%-3.79M
29.95%16.19M
-58.11%1.93M
--4.75M
--4.88M
--4.64M
--12.46M
--4.6M
Change In working capital
-365.56%-8.56M
-55.41%1.59M
-194.57%-7.25M
-232.58%-2.18M
---6.8M
---1.84M
--3.57M
--7.66M
--1.64M
-Change in receivables
30.21%-700K
-101.70%-1.66M
55.89%-1.94M
162.28%591K
---704K
---1M
---825K
---4.4M
---949K
-Change in inventory
-8.63%-1.88M
67.11%-716K
-856.97%-8.36M
-584.64%-1.74M
---2.72M
---1.73M
---2.18M
--1.1M
--358K
-Change in prepaid assets
39.85%186K
205.45%290K
-251.99%-2.83M
-1,017.14%-782K
---1.91M
--133K
---275K
---804K
---70K
-Change in payables and accrued expense
-990.31%-7.17M
-52.55%3.28M
-48.39%5.47M
-157.66%-1.01M
---1.25M
--805K
--6.92M
--10.59M
--1.75M
-Change in other working capital
2,225.53%999K
607.69%396K
-64.76%413K
37.07%758K
---220K
---47K
---78K
--1.17M
--553K
Cash from discontinued investing activities
Operating cash flow
-17.51%-17.5M
-145.21%-17.27M
-5.31%-43.79M
-57.70%-9.33M
---12.52M
---14.89M
---7.04M
---41.58M
---5.92M
Investing cash flow
Cash flow from continuing investing activities
0
9.09%-10K
60.32%-25K
-400.00%-5K
0
-9K
-11K
-63K
-1K
Net PPE purchase and sale
--0
9.09%-10K
60.32%-25K
-400.00%-5K
--0
---9K
---11K
---63K
---1K
Cash from discontinued investing activities
Investing cash flow
--0
9.09%-10K
60.32%-25K
-400.00%-5K
--0
---9K
---11K
---63K
---1K
Financing cash flow
Cash flow from continuing financing activities
54.56%27.54M
0
33.40%62.99M
13.8M
24.19M
17.82M
7.18M
47.22M
0
Net issuance payments of debt
--0
--0
-36.57%32.18M
---1K
--7.18M
--17.82M
--7.18M
--50.74M
--0
Net common stock issuance
----
----
--13.8M
----
----
----
----
--0
----
Net other financing activities
----
----
583.76%17.01M
--1K
----
----
----
---3.52M
--0
Cash from discontinued financing activities
Financing cash flow
54.56%27.54M
--0
33.40%62.99M
--13.8M
--24.19M
--17.82M
--7.18M
--47.22M
--0
Net cash flow
Beginning cash position
24.08%9.14M
265.20%26.42M
336.78%7.23M
66.90%21.95M
--10.28M
--7.36M
--7.23M
--1.66M
--13.15M
Current changes in cash
244.41%10.04M
-13,289.31%-17.28M
243.95%19.18M
175.37%4.46M
--11.68M
--2.91M
--131K
--5.58M
---5.92M
End cash Position
86.54%19.17M
24.08%9.14M
265.20%26.42M
265.20%26.42M
--21.95M
--10.28M
--7.36M
--7.23M
--7.23M
Free cash flow
-17.44%-17.5M
-144.97%-17.28M
-5.21%-43.81M
-57.75%-9.34M
---12.52M
---14.9M
---7.05M
---41.64M
---5.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.51%-17.5M-145.21%-17.27M-5.31%-43.79M-57.70%-9.33M-12.52M-14.89M-7.04M-41.58M-5.92M
Net income from continuing operations 40.97%-10.69M3.62%-14.87M-1,034.80%-40.62M-1,647.48%-4.3M---2.77M---18.12M---15.43M--4.35M--278K
Operating gains losses ---728K---642K80.86%-12.8M62.43%-4.9M---------------66.89M---13.04M
Depreciation and amortization 0.00%7K40.00%7K38.89%25K75.00%7K--6K--7K--5K--18K--4K
Other non cash items -58.58%2.02M-181.57%-3.79M29.95%16.19M-58.11%1.93M--4.75M--4.88M--4.64M--12.46M--4.6M
Change In working capital -365.56%-8.56M-55.41%1.59M-194.57%-7.25M-232.58%-2.18M---6.8M---1.84M--3.57M--7.66M--1.64M
-Change in receivables 30.21%-700K-101.70%-1.66M55.89%-1.94M162.28%591K---704K---1M---825K---4.4M---949K
-Change in inventory -8.63%-1.88M67.11%-716K-856.97%-8.36M-584.64%-1.74M---2.72M---1.73M---2.18M--1.1M--358K
-Change in prepaid assets 39.85%186K205.45%290K-251.99%-2.83M-1,017.14%-782K---1.91M--133K---275K---804K---70K
-Change in payables and accrued expense -990.31%-7.17M-52.55%3.28M-48.39%5.47M-157.66%-1.01M---1.25M--805K--6.92M--10.59M--1.75M
-Change in other working capital 2,225.53%999K607.69%396K-64.76%413K37.07%758K---220K---47K---78K--1.17M--553K
Cash from discontinued investing activities
Operating cash flow -17.51%-17.5M-145.21%-17.27M-5.31%-43.79M-57.70%-9.33M---12.52M---14.89M---7.04M---41.58M---5.92M
Investing cash flow
Cash flow from continuing investing activities 09.09%-10K60.32%-25K-400.00%-5K0-9K-11K-63K-1K
Net PPE purchase and sale --09.09%-10K60.32%-25K-400.00%-5K--0---9K---11K---63K---1K
Cash from discontinued investing activities
Investing cash flow --09.09%-10K60.32%-25K-400.00%-5K--0---9K---11K---63K---1K
Financing cash flow
Cash flow from continuing financing activities 54.56%27.54M033.40%62.99M13.8M24.19M17.82M7.18M47.22M0
Net issuance payments of debt --0--0-36.57%32.18M---1K--7.18M--17.82M--7.18M--50.74M--0
Net common stock issuance ----------13.8M------------------0----
Net other financing activities --------583.76%17.01M--1K---------------3.52M--0
Cash from discontinued financing activities
Financing cash flow 54.56%27.54M--033.40%62.99M--13.8M--24.19M--17.82M--7.18M--47.22M--0
Net cash flow
Beginning cash position 24.08%9.14M265.20%26.42M336.78%7.23M66.90%21.95M--10.28M--7.36M--7.23M--1.66M--13.15M
Current changes in cash 244.41%10.04M-13,289.31%-17.28M243.95%19.18M175.37%4.46M--11.68M--2.91M--131K--5.58M---5.92M
End cash Position 86.54%19.17M24.08%9.14M265.20%26.42M265.20%26.42M--21.95M--10.28M--7.36M--7.23M--7.23M
Free cash flow -17.44%-17.5M-144.97%-17.28M-5.21%-43.81M-57.75%-9.34M---12.52M---14.9M---7.05M---41.64M---5.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data